Sarcoma Cancers News Articles | Treatment & Drug Studies

Sarcoma News

SARCOMA CANCER ADVISOR

Sarcoma News

FDA_drug approval

Tazverik Gets FDA Approval for Epithelioid Sarcoma

The FDA has granted accelerated approval to Tazverik™ (tazemetostat tablets; Epizyme) for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.